For the millions of caregivers and clinicians managing mild cognitive impairment and dementia, choosing among music, art, dance, or game-based interventions has largely been guesswork. A new network meta-analysis now provides the most comprehensive head-to-head ranking of seven recreational therapies simultaneously — offering a data-driven framework for non-pharmacological care decisions that could reshape clinical protocols worldwide.
Drawing on randomized controlled trials sourced from eight major databases including MEDLINE, Embase, CINAHL, and Scopus, this frequentist network meta-analysis applied random-effects modeling to compare music therapy, singing therapy, dance therapy, art therapy, game therapy, creative story therapy, and combined therapy across a multi-dimensional outcome hierarchy. Primary outcomes were stratified across four cognitive tiers — global cognition, fundamental processes (immediate and delayed memory, attention, processing speed), intermediate processes (language, verbal fluency), and higher-order executive function — while secondary outcomes captured neuropsychiatric symptoms, depression, anxiety, and quality of life. Standardized mean differences and Netrank scoring were used to establish intervention hierarchies across these distinct cognitive domains.
What makes this analysis particularly valuable is the domain-specificity of its rankings. Rather than declaring a single universal winner, the data suggest that different therapies may confer advantages on different cognitive and psychosocial dimensions — a nuance that prior pairwise meta-analyses could not resolve. This aligns with emerging neuroscience showing that music processing, motor learning (dance), and narrative construction (creative story therapy) recruit partially distinct neural circuits, meaning therapy choice should arguably be matched to the patient's specific deficit profile rather than applied uniformly. The network design also reduces the indirect comparison bias inherent in conventional meta-analyses, strengthening its inferential power.
Key limitations remain: heterogeneity across RCT protocols, session dosages, and dementia severity stages is a persistent challenge in this literature, and the excerpt does not confirm whether all seven arms had sufficient direct comparison data to stabilize estimates. Clinicians should treat the rankings as probabilistic guides rather than definitive prescriptions. Nevertheless, for a field historically reliant on small single-therapy trials, this analysis represents a meaningful methodological step forward.